DK1078051T3 - Fagvisningsselektionssystem til selektion af korrekt foldede proteiner - Google Patents

Fagvisningsselektionssystem til selektion af korrekt foldede proteiner

Info

Publication number
DK1078051T3
DK1078051T3 DK99922306T DK99922306T DK1078051T3 DK 1078051 T3 DK1078051 T3 DK 1078051T3 DK 99922306 T DK99922306 T DK 99922306T DK 99922306 T DK99922306 T DK 99922306T DK 1078051 T3 DK1078051 T3 DK 1078051T3
Authority
DK
Denmark
Prior art keywords
selection
virus
polypeptide
phage display
properly folded
Prior art date
Application number
DK99922306T
Other languages
Danish (da)
English (en)
Inventor
Peter Kristensen
Lutz Riechmann
Jean-Luc Jestin
Gregory Paul Winter
Original Assignee
Domantis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810223.9A external-priority patent/GB9810223D0/en
Priority claimed from GBGB9810228.8A external-priority patent/GB9810228D0/en
Application filed by Domantis Ltd filed Critical Domantis Ltd
Application granted granted Critical
Publication of DK1078051T3 publication Critical patent/DK1078051T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/02Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Air Bags (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Circuits Of Receivers In General (AREA)
  • Vehicle Body Suspensions (AREA)
DK99922306T 1998-05-13 1999-05-13 Fagvisningsselektionssystem til selektion af korrekt foldede proteiner DK1078051T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9810223.9A GB9810223D0 (en) 1998-05-13 1998-05-13 Selection system
GBGB9810228.8A GB9810228D0 (en) 1998-05-13 1998-05-13 Selection method
PCT/GB1999/001526 WO1999058655A2 (en) 1998-05-13 1999-05-13 Phage display selection system for folded proteins

Publications (1)

Publication Number Publication Date
DK1078051T3 true DK1078051T3 (da) 2008-04-07

Family

ID=26313668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99922306T DK1078051T3 (da) 1998-05-13 1999-05-13 Fagvisningsselektionssystem til selektion af korrekt foldede proteiner

Country Status (14)

Country Link
US (2) US7442159B1 (ja)
EP (2) EP1950295A1 (ja)
JP (2) JP4493846B2 (ja)
AT (1) ATE380865T1 (ja)
AU (1) AU762814B2 (ja)
CA (1) CA2328422A1 (ja)
CY (1) CY1107293T1 (ja)
DE (1) DE69937735T2 (ja)
DK (1) DK1078051T3 (ja)
ES (1) ES2299244T3 (ja)
GB (1) GB2361237A (ja)
NO (1) NO329172B1 (ja)
PT (1) PT1078051E (ja)
WO (1) WO1999058655A2 (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1100890A2 (en) 1998-07-27 2001-05-23 Genentech, Inc. Improved transformation efficiency in phage display through modification of a coat protein
DK1144607T5 (da) 1999-07-20 2009-10-05 Morphosys Ag Fremgangsmåde til præsentation af (poly)peptider/proteiner på bakteriofage partikler via disulfidbindinger
WO2001057065A2 (en) * 2000-02-03 2001-08-09 Domantis Limited Combinatorial protein domains
GB0019049D0 (en) * 2000-08-04 2000-09-27 Neutec Pharma Plc Combinatorial chemistry method
WO2002012277A2 (en) * 2000-08-07 2002-02-14 Domantis Limited Hybrid combinatorial proteins made from reshuffling of differently folded domains
DE10135039C1 (de) * 2001-07-18 2003-03-13 Nemod Immuntherapie Ag Verfahren zur Isolierung großer Varianzen spezifischer Moleküle für ein Zielmolekül aus Phagemid-Gen-Bibliotheken
WO2004101790A1 (en) 2003-05-14 2004-11-25 Domantis Limited A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
RU2412249C2 (ru) 2005-07-08 2011-02-20 Юниверсити Оф Цюрих Фаговый дисплей с применением котрансляционной транслокации слитых полипептидов
GB2428293A (en) * 2005-07-13 2007-01-24 Domantis Ltd Phage display libraries
WO2007010525A2 (en) 2005-07-21 2007-01-25 Aebi Ltd. Methods and compositions for identifying a peptide having an intermolecular interaction with a target of interest
GB0515115D0 (en) 2005-07-22 2005-08-31 Isogenica Ltd Peptide characterisation
AU2007262635B2 (en) * 2006-06-23 2014-09-11 Adc Therapeutics Sa Polynucleotides and polypeptide sequences involved in cancer
KR20100018040A (ko) 2007-06-06 2010-02-16 도만티스 리미티드 프로테아제 내성 폴리펩티드를 선택하는 방법
ES2403904T3 (es) 2007-08-21 2013-05-22 Morphosys Ag Métodos para la formación de enlaces disulfuro
ES2614284T3 (es) 2007-11-30 2017-05-30 Glaxo Group Limited Construcciones de unión a antígenos
AU2009321508B2 (en) 2008-11-03 2015-03-12 Adc Therapeutics Sa Antibodies that specifically block the biological activity of a tumor antigen
BRPI0922772B1 (pt) 2008-12-05 2021-09-08 Glaxo Group Limited Domínio variável único de imunoglobulina e polipeptídeos isolados
CA2753287A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Antigen-binding constructs
JP2012518399A (ja) 2009-02-24 2012-08-16 グラクソ グループ リミテッド 抗原結合性構築物
WO2010097394A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Multivalent and/or multispecific rankl-binding constructs
MX2013005847A (es) 2010-11-24 2013-12-12 Glaxo Group Ltd Proteinas de union a antigeno multiespecificas que eligen como blanco a hgf.
BR112013025198A2 (pt) 2011-03-31 2018-12-04 Alethia Biotherapeutics Inc. anticorpos contra antígeno 1 associado a rim e fragmentos de ligação a antígeno do mesmo
PE20141659A1 (es) 2011-07-27 2014-11-21 Glaxo Group Ltd Dominios variables singulares anti-vgf fusionados con dominios de fc
EP3431589A1 (en) * 2011-10-27 2019-01-23 The Governors of the University of Alberta Device and method for bacterial culture and assay
PL2802351T3 (pl) 2012-01-09 2019-11-29 Adc Therapeutics Sa Środki do leczenia potrójnie negatywnego raka piersi
MX2016003957A (es) 2013-09-25 2017-02-02 Cytomx Therapeutics Inc Substratos de metaloproteinasas de matriz y otras porciones escindibles y metodos para usar los mismos.
JP6835586B2 (ja) 2014-01-31 2021-02-24 シトムクス セラピューティクス,インコーポレイティド マトリプターゼ及びu‐プラスミノーゲン活性化因子の基質及び他の切断可能部分、並びにその使用方法
EP3218479A1 (en) * 2014-11-11 2017-09-20 Nanocore ApS Method for identification of molecules with desired characteristics
MA41374A (fr) 2015-01-20 2017-11-28 Cytomx Therapeutics Inc Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
KR20170132154A (ko) * 2015-03-31 2017-12-01 브이에이치스퀘어드 리미티드 프로테아제-절단가능 링커를 갖는 펩티드 구조물
US20220228172A1 (en) * 2019-06-21 2022-07-21 Boehringer Ingelheim International Gmbh Novel Mechanism to Control RNA Virus Replication and Gene Expression

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
WO1990005144A1 (en) 1988-11-11 1990-05-17 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
GB9015198D0 (en) * 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ATE185601T1 (de) * 1990-07-10 1999-10-15 Cambridge Antibody Tech Verfahren zur herstellung von spezifischen bindungspaargliedern
EP0575485A1 (en) * 1991-03-01 1993-12-29 Dyax Corp. Process for the development of binding mini-proteins
DE4122599C2 (de) * 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
PT1696031E (pt) 1991-12-02 2010-06-25 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos

Also Published As

Publication number Publication date
JP4493846B2 (ja) 2010-06-30
GB2361237A (en) 2001-10-17
AU762814B2 (en) 2003-07-03
JP2010148507A (ja) 2010-07-08
CA2328422A1 (en) 1999-11-18
US8680018B2 (en) 2014-03-25
EP1950295A1 (en) 2008-07-30
CY1107293T1 (el) 2012-11-21
GB0026143D0 (en) 2000-12-13
US20090203542A1 (en) 2009-08-13
JP5161865B2 (ja) 2013-03-13
JP2002514413A (ja) 2002-05-21
EP1078051A2 (en) 2001-02-28
PT1078051E (pt) 2008-03-17
NO20005628L (no) 2001-01-12
WO1999058655A3 (en) 2000-01-27
US7442159B1 (en) 2008-10-28
NO20005628D0 (no) 2000-11-08
DE69937735T2 (de) 2008-11-27
AU3941399A (en) 1999-11-29
NO329172B1 (no) 2010-09-06
ES2299244T3 (es) 2008-05-16
DE69937735D1 (de) 2008-01-24
WO1999058655A2 (en) 1999-11-18
EP1078051B1 (en) 2007-12-12
ATE380865T1 (de) 2007-12-15

Similar Documents

Publication Publication Date Title
DK1078051T3 (da) Fagvisningsselektionssystem til selektion af korrekt foldede proteiner
DK0816506T3 (da) System til ekspression af heterologe antigener som fusionsproteiner
DK1088084T3 (da) Erythropoietin analog-humant serumalbumin fusionsprotein
NZ521396A (en) Fusion proteins comprising two or more Neisseria polypeptides
DK0547201T3 (da) Fagmid til screening af antistoffer
BR9810654B1 (pt) mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
AR009436A1 (es) UNA PROTEíNA DE FUSIoN FC-OB, UNA SECUENCIA DE ÁCIDO NUCLEICO QUE LA CODIFICA, UN VECTOR, PROCEDIMIENTO DE PREPARACIoN, COMPOSICIONES FARMACÉUTICAS Y USOS.
DE69633563D1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
DK0977873T3 (da) Fremgangsmåde til spaltning af fusionsproteiner
AU2002235884A1 (en) Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith
DE69531235D1 (de) Säugetier - Expressionssysteme für Hüllenprotingene des Hepatitit - C - Virus
NO20052552D0 (no) Loselige Notch-baserte substrater for gamma-sekretase og fremgangsmater og blandinger for anvendelse av samme.
WO1998039421A3 (en) Mammalian proteinases; oxidoreductases; gtp binding proteins; related reagents
ATE397081T1 (de) Erhöhte expression von proteinen mittels gfp
WO2000031127A3 (en) Protein fragments for use in protein targeting
DE69611896D1 (de) Fusions-DNS-Sequenz, dadurch exprimiertes Fusionsprotein und Verfahren zur Expression dieses Fusionsproteins
IS5174A (is) Aðferð til framleiðslu á O-(3-amínó-2-hýdroxý-própýl)-hýdroxýmsýru halíð
DK1078072T3 (da) Nye peptidfragmenter til oprensning af proteiner
WO2000034294A3 (en) Tumor necrosis factor receptor homologue-1 ('trh1')
WO1997039020A3 (en) Antigenic sequences of a sperm protein and immunocontraceptive methods
DE59105878D1 (de) VERFAHREN ZUR ENZYMATISCHEN SPALTUNG REKOMBINANTER PROTEINE UNTER VERWENDUNG VON IgA-PROTEASEN.